It was proposed as a potential prognostic marker in CRC-II patients as it is a significant component of the CXCL10/CXCR3 axis of inflammatory mediators thought to be a lymphocyte-associated metastasis mediator in several cancer types. The gene discussed is CXCR3; the disease is colorectal carcinoma.